|
|
|
 |
01 Aegen Biosciences, Inc.
  Aegen Biosciences, Inc., a small biotechnology company in Monterey, CA, uses Cornell University discoveries to develop next-generation analytical tools for toxicology, drug discovery, drug development, pharmacogenomics, and clinical diagnostics. Aegen is developing an animal-on-a-chip device based on technology invented at Cornell by Michael L. Shuler, Chemical Engineering, and Gregory T. Baxter, formerly senior research associate, now president/CEO of Aegen. Commercialization of the technology has the potential to increase the success rates and decrease the development time of marketable drugs, while greatly reducing the number of animals used during preclinical studies.> Back / > Next Article / > Back to Listing © 2002 by the Office of the Vice Provost for Research [OVPR], Cornell University. |
|
314 Day Hall Ithaca, New York 14853-2801 P: 607.255.7200 F: 607.255.9030 E: VP Research C: Credits  |
||||||||
